Absci Corp (ABSI)

$3.09 +0.07 (2.32%)
Market Cap 449.61M
Revenue (ttm) 4.53M
Net Income (ttm) -103.11M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,276.16%
Debt to Equity Ratio 0.01
Volume 3,199,400
Avg Vol 3,683,966
Day's Range N/A - N/A
Shares Out 150.37M
Stochastic %K 68%
Beta 2.11
Analysts Strong Sell
Price Target $8.04

Company Profile

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agree...

Industry: Biotechnology
Sector: Healthcare
Phone: 360 949 1041
Address:
18105 SE Mill Plain Boulevard, Vancouver, United States
JennyRowes
JennyRowes Feb. 2 at 4:22 PM
$ABSI bitcoin crashing mag seven flat gold and silver crashing is it time for AI drug development? for smallcap? for bio??
0 · Reply
flam70
flam70 Jan. 30 at 7:13 PM
$ABSI looks like vanguard added another 700k shares from 7.2mm to 7.9
0 · Reply
Maksiuland
Maksiuland Jan. 29 at 6:03 PM
$ABSI Why is it suddently going up?
2 · Reply
Andymac1966
Andymac1966 Jan. 27 at 8:24 PM
$ABSI
0 · Reply
MAs_Crxss
MAs_Crxss Jan. 27 at 9:22 AM
$ABSI most bio players don’t believe in technicals.
3 · Reply
Maksiuland
Maksiuland Jan. 24 at 3:59 PM
$ABSI https://www.youtube.com/watch?v=GmUjZC9PNfc
1 · Reply
Maksiuland
Maksiuland Jan. 24 at 3:58 PM
$ABSI Those who sold will regret it once they will see this going up to $12 in no time...
0 · Reply
musky54
musky54 Jan. 23 at 5:57 PM
$ABSI low volume takedown
0 · Reply
Maksiuland
Maksiuland Jan. 23 at 5:00 PM
0 · Reply
Mike_Rotsch
Mike_Rotsch Jan. 23 at 4:32 PM
$ABSI Okay now, that's enough.
0 · Reply
Latest News on ABSI
Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 14, 2026, 10:16 PM EST - 20 days ago

Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 16, 2025, 8:00 AM EST - 7 weeks ago

Absci to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Absci Corporation (ABSI) Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia Transcript

Dec 11, 2025, 4:52 PM EST - 7 weeks ago

Absci Corporation (ABSI) Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia Transcript

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Dec 11, 2025, 8:00 AM EST - 7 weeks ago

Absci Reports New Human Ex Vivo Data Demonstrating That ABS-201™ Stimulates Hair Growth and Regenerates Stem Cell Niche to Potentially Reverse Follicle Miniaturization

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Dec 10, 2025, 8:00 AM EST - 7 weeks ago

Absci and U.S. Soccer Legend Landon Donovan Partner to Champion the Patient Voice in Hair Loss Research

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Dec 4, 2025, 8:00 AM EST - 2 months ago

Absci Announces First Participants Dosed in Phase 1/2a HEADLINE™ Trial of AI-Designed Antibody ABS-201™ for Androgenetic Alopecia

Absci Corporation (ABSI) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 21, 2025, 7:23 PM EST - 2 months ago

Absci Corporation (ABSI) Presents at Jefferies London Healthcare Conference 2025 Transcript

Absci Corporation (ABSI) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 10:31 PM EST - 2 months ago

Absci Corporation (ABSI) Q3 2025 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Nov 12, 2025, 4:05 PM EST - 2 months ago

Absci Reports Business Updates and Third Quarter 2025 Financial and Operating Results

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Oct 29, 2025, 4:05 PM EDT - 3 months ago

Absci to Report Business Updates and Third Quarter 2025 Financial and Operating Results on November 12, 2025

Absci to Participate in Upcoming Investor Conferences

Oct 27, 2025, 8:00 AM EDT - 3 months ago

Absci to Participate in Upcoming Investor Conferences

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Oct 15, 2025, 8:00 AM EDT - 4 months ago

Absci to Host KOL Seminar on ABS-201 Androgenetic Alopecia Program on December 11, 2025; Announces Accelerated Initiation of Phase 1/2a Trial

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

Sep 11, 2025, 12:10 PM EDT - 5 months ago

Absci Boosts AI-Powered Drug Discovery With Oracle And AMD Collaboration

AMD ORCL

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Sep 11, 2025, 8:00 AM EDT - 5 months ago

Absci Accelerates AI-Driven Drug Discovery with Oracle and AMD

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 12:13 AM EDT - 5 months ago

Absci Corporation (ABSI) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Aug 25, 2025, 4:05 PM EDT - 5 months ago

Absci Expands ABS-201 Scientific Advisory Board with Addition of Leading Dermatology Experts Dr. Rodney Sinclair and Dr. David Goldberg

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 12:25 AM EDT - 6 months ago

Absci Corporation (ABSI) Q2 2025 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Aug 12, 2025, 4:05 PM EDT - 6 months ago

Absci Reports Business Updates and Second Quarter 2025 Financial and Operating Results

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Aug 7, 2025, 2:00 AM EDT - 6 months ago

Almirall and Absci Expand AI Drug Creation Collaboration Adding a Second Dermatology Target

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Jul 30, 2025, 4:05 PM EDT - 6 months ago

Absci to Report Business Updates and Second Quarter 2025 Financial and Operating Results on August 12, 2025

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Jul 25, 2025, 8:34 AM EDT - 6 months ago

Intel, Absci, AST SpaceMobile And Other Big Stocks Moving Lower In Friday's Pre-Market Session

ASTS INTC

Absci Announces Pricing of Public Offering of Common Stock

Jul 24, 2025, 8:45 PM EDT - 6 months ago

Absci Announces Pricing of Public Offering of Common Stock

Absci Announces Proposed Public Offering of Common Stock

Jul 24, 2025, 4:54 PM EDT - 6 months ago

Absci Announces Proposed Public Offering of Common Stock

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Jul 7, 2025, 8:00 AM EDT - 7 months ago

Absci Appoints Biopharma Leader Mary Szela to Board of Directors

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

May 13, 2025, 10:45 PM EDT - 9 months ago

Absci Corporation (ABSI) Q1 2025 Earnings Call Transcript

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

May 13, 2025, 4:05 PM EDT - 9 months ago

Absci Reports Business Updates and First Quarter 2025 Financial and Operating Results

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

May 13, 2025, 4:01 PM EDT - 9 months ago

Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Apr 14, 2025, 4:05 PM EDT - 10 months ago

Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Apr 3, 2025, 3:15 PM EDT - 10 months ago

Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Mar 19, 2025, 8:15 AM EDT - 11 months ago

Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

HQY TNXP

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Mar 18, 2025, 7:37 PM EDT - 11 months ago

Absci Corporation (ABSI) Q4 2024 Earnings Call Transcript

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Mar 18, 2025, 4:05 PM EDT - 11 months ago

Absci Reports Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Mar 4, 2025, 4:05 PM EST - 1 year ago

Absci to Report Business Updates and Fourth Quarter and Full Year 2024 Financial and Operating Results on March 18, 2025

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 4, 2025, 4:00 PM EST - 1 year ago

Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Mar 4, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the KeyBanc Capital Markets Healthcare Forum

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Feb 18, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the TD Cowen 45th Annual Health Care Conference

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

Jan 22, 2025, 1:22 PM EST - 1 year ago

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside

AMD

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Jan 22, 2025, 8:00 AM EST - 1 year ago

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

Jan 13, 2025, 2:05 AM EST - 1 year ago

Absci Looks Cheap And Positioned For Growth With AMD's AI Backing

AMD

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Jan 10, 2025, 7:30 AM EST - 1 year ago

Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Jan 8, 2025, 7:00 AM EST - 1 year ago

Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Jan 6, 2025, 8:00 AM EST - 1 year ago

Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 10:01 AM EST - 1 year ago

Absci Corporation (ABSI) Q3 2024 Earnings Call Transcript

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Nov 12, 2024, 7:30 AM EST - 1 year ago

Absci Reports Business Updates and Third Quarter 2024 Financial and Operating Results

Absci to Host R&D Day on December 12, 2024

Nov 7, 2024, 8:00 AM EST - 1 year ago

Absci to Host R&D Day on December 12, 2024

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Absci to Report Business Updates and Third Quarter 2024 Financial and Operating Results on November 12, 2024

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Oct 3, 2024, 12:36 PM EDT - 1 year ago

Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Aug 16, 2024, 11:50 PM EDT - 1 year ago

Absci Corporation (ABSI) Q2 2024 Earnings Call Transcript

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Aug 14, 2024, 4:01 PM EDT - 1 year ago

Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

Aug 12, 2024, 8:00 AM EDT - 1 year ago

Absci Collaborates with Global Cancer Center to Discover Novel Therapeutics Using Generative AI

JennyRowes
JennyRowes Feb. 2 at 4:22 PM
$ABSI bitcoin crashing mag seven flat gold and silver crashing is it time for AI drug development? for smallcap? for bio??
0 · Reply
flam70
flam70 Jan. 30 at 7:13 PM
$ABSI looks like vanguard added another 700k shares from 7.2mm to 7.9
0 · Reply
Maksiuland
Maksiuland Jan. 29 at 6:03 PM
$ABSI Why is it suddently going up?
2 · Reply
Andymac1966
Andymac1966 Jan. 27 at 8:24 PM
$ABSI
0 · Reply
MAs_Crxss
MAs_Crxss Jan. 27 at 9:22 AM
$ABSI most bio players don’t believe in technicals.
3 · Reply
Maksiuland
Maksiuland Jan. 24 at 3:59 PM
$ABSI https://www.youtube.com/watch?v=GmUjZC9PNfc
1 · Reply
Maksiuland
Maksiuland Jan. 24 at 3:58 PM
$ABSI Those who sold will regret it once they will see this going up to $12 in no time...
0 · Reply
musky54
musky54 Jan. 23 at 5:57 PM
$ABSI low volume takedown
0 · Reply
Maksiuland
Maksiuland Jan. 23 at 5:00 PM
0 · Reply
Mike_Rotsch
Mike_Rotsch Jan. 23 at 4:32 PM
$ABSI Okay now, that's enough.
0 · Reply
nesanmano
nesanmano Jan. 22 at 10:16 PM
$ABSI when will this go up
1 · Reply
flam70
flam70 Jan. 21 at 4:46 PM
$ABSI
2 · Reply
Mart7810
Mart7810 Jan. 20 at 10:34 PM
$ABSI
0 · Reply
musky54
musky54 Jan. 20 at 10:04 PM
$ABSI 65% of shares held by institutions
1 · Reply
Mart7810
Mart7810 Jan. 17 at 9:40 PM
$ABSI waiting the low 2$ to come back in
1 · Reply
JennyRowes
JennyRowes Jan. 17 at 3:41 PM
$ABSI $RXRX listen to both RXRX and ABSI presentations. Najat seems more confident and polished. Would love to see both companies brought under one strong leader.
3 · Reply
JennyRowes
JennyRowes Jan. 17 at 3:33 PM
$ABSI just listened to JPM presentation. ABSI201 is interesting. generally positive, although Sean sounded a bit flat. maybe just nervous
2 · Reply
Jacob6444
Jacob6444 Jan. 16 at 1:52 AM
$ABSI it for sure will, just gonna take something substantial. I think they are getting close to oversold once again. May need to grab me some more again.
0 · Reply
JennyRowes
JennyRowes Jan. 15 at 8:28 PM
$ABSI Anyone think $RXRX might buy $ABSI ? They added small molecule AI with Exscientia so feels like antibody AI would be the natural evolution…
0 · Reply
Heather_Swanson
Heather_Swanson Jan. 15 at 7:15 PM
$ABSI does this have a chance to every blow up? What are we waiting for?
1 · Reply
BioHunter1
BioHunter1 Jan. 15 at 6:41 PM
$ABSI Thank goodness I got out on time with some profits. Around 2% after 2 years of holding. GL
0 · Reply
LabPsycho
LabPsycho Jan. 15 at 6:08 PM
$ABSI @Kernmantel Outstanding post! Cash to market cap is a concern to me as is Wall St. doesn't seem to be falling for the A.I. drug discovery hype any more. RXRX has their own issues IMO.
0 · Reply